States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them ...

In 2022, the American Cancer Society (ACS) updated its nutrition and activity guidelines for cancer survivors, recommending ...

As the old saying goes, “an ounce of prevention is worth a pound of cure,” and in my decades of experience in healthcare that ...

Obesity is at epidemic proportions in the United States where more than 40% of adults are obese and more than 70% are overweight. One common policy intervention to tackle this urgent issue is to try ...

New research published in the Lancet finds that obesity related deaths are on the rise and the obesity epidemic continues to ...

The Ministry of Health and Prevention (MoHAP) has launched several initiatives over the course of the past year 2024 in ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

The results suggest that societal and early-life risk factors could be used to target obesity prevention programs for ...

These findings have particular relevance for nutritional guidance and obesity prevention programs. Rather than focusing solely on food content, interventions could incorporate guidance on eating ...

New research to be presented at this year's European Congress on Obesity (ECO 2025 ... Lyn Baker of The Center for Clinical Research and Prevention, Copenhagen University Hospital - Bispebjerg ...

“The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India. Lilly is committed to collaborating with the government and industry to promote ...

Obesity has emerged as a significant public health concern, affecting millions worldwide. While its impact on cardiovascular health and diabetes is well-known, a lesser-discussed but equally critical ...